REQUEST A DEMO
Total
USD $0.00
Search more companies

Prestige Biologics Co., Ltd. (South Korea)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Prestige Biologics Co., Ltd. Profile Updated: October 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

The company is a Korean-based company mainly engaged in the business of developing and manufacturing biopharmaceuticals. The Company mainly engages in the contract manufacturing service business that produces and supplies biopharmaceuticals; and contract development service business that provides development services including cell culture process and purification process. The Company was established on June 2, 2015. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on March 11, 2021.

Headquarters
197, Osongsaengmyeong 1-Ro, Osong-Eup, Heungdeok-Gu
Cheongju; Chungcheongbuk;

Contact Details: Purchase the Prestige Biologics Co., Ltd. report to view the information.

Website: http://www.prestigebiologics.com

Basic Information
Total Employees:
Purchase the Prestige Biologics Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Prestige Biologics Co., Ltd. report to view the information.
Registered Capital:
Purchase the Prestige Biologics Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Prestige Biologics Co., Ltd. report to view the information.
Incorporation Date:
June 02, 2015
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Subsidiaries
프레스티지바이오로직스(주)
프레스티지바이오파마
Company Performance
Financial values in the chart are available after Prestige Biologics Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
13834.49%
Total operating revenue
3268.77%
Operating profit (EBIT)
42.97%
EBITDA
65.48%
Net Profit (Loss) for the Period
40.92%
Total assets
12.14%
Total equity
-39.05%
Operating Profit Margin (ROS)
236850.55%
Net Profit Margin
318046.41%
Return on Equity (ROE)
1.29%
Debt to Equity Ratio
140.54%
Quick Ratio
-0.14%
Cash Ratio
-0.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?